Caudal or Interlaminar Epidural Steroid Injections
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.164 alerts
Get alerted when Policy CP.MP.164 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, coverage criteria, and coding guidance for caudal and interlaminar epidural steroid injections for acute and chronic radicular/spinal pain for members/enrollees of the Health Plan.
No material clinical or coverage changes in this revision.
Coverage Criteria for Caudal and Interlaminar Epidural Steroid Injections
inv-01: Acute pain indication
Covered when ALL of the following are met
Severe radicular pain that interferes substantially with activities of daily living (ADLs); severe pain persists after NSAID and/or opiate trial (both ≥ 3 days) or these agents are contraindicated/not tolerated; member cannot tolerate chiropractic or physical therapy and injection is intended as a bridge to therapy.
inv-02: Initial ESI for chronic pain
Covered when ALL of the following are met
Persistent radicular pain caused by spinal stenosis, disc herniation, or degenerative vertebral changes confirmed by physical exam and imaging; pain interferes with ADLs and has lasted ≥ 3 months; failed conservative therapy including: (a) ≥ 4 weeks chiropractic, physical therapy, or prescribed home exercise program; (b) NSAID for ≥ 3 weeks or NSAID contraindicated/not tolerated; (c) ≥ 4 weeks activity modification.
inv-03: Second ESI when first ineffective
Covered when ALL of the following are met
Used when chronic pain did not improve from the first ESI.
inv-04: Subsequent ESI after prior successful response
Covered when ALL of the following are met
inv-05: Not medically necessary
Consideration may be given on a case‑by‑case basis when more definitive therapies cannot be tolerated or provided.
It is the policy of the Health Plan that caudal or interlaminar epidural steroid injections (ESI) for any indication or anatomic location not specified in the coverage criteria are not medically necessary because effectiveness has not been established.
A third or subsequent caudal or interlaminar ESI for chronic pain that did not improve from the first two ESIs is considered not medically necessary. Additionally, continuation of injections beyond 12 months or administering more than four therapeutic injections within any 12‑month period is considered not medically necessary because effectiveness and safety have not been established; exceptions may be considered on a case‑by‑case basis when definitive therapies cannot be tolerated or provided.
Conservative Treatment Required Before Injections
inv-18: Complete conservative therapy before initial chronic ESI
Complete conservative therapy is required before an initial chronic ESI; duration varies by modality
These conservative measures must be documented in the clinical record before authorizing an initial chronic ESI.
Frequency and Interval Limits for Epidural Steroid Injections
Procedure Codes and Pain-Relief Thresholds
| 62320 | Injection(s) interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance. |
| 62321 | Injection(s) interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance. |
| 62322 | Injection(s) interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance. |
| 62323 | Injection(s) interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance. |
| 62324 | Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance (description truncated in policy). |
| 62325 | Interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (description in policy). |
| 62326 | Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance. |
| 62327 | Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance. |
Provider Actions, Documentation, and Authorization
Prior Authorization Required
Prior authorization is required for caudal or interlaminar epidural steroid injections (ESIs). Requests must document that only one procedure will be performed per visit and that imaging guidance will be used (or provide documented justification if imaging guidance is not used).
- Prior authorization required for caudal/interlaminar ESIs
- Only one procedure per visit
- Imaging guidance generally required; if not used, provide documented justification
Conservative Therapy Requirement
For initial chronic pain ESI requests, the member must have attempted conservative therapy prior to authorization, including physical therapy/chiropractic or a prescribed home exercise program, a trial of NSAID therapy, and activity modification. A single caudal or interlaminar ESI may be authorized for acute pain (<3 months) only when severe radicular pain interferes with ADLs and NSAIDs/opioids have been tried (≥3 days) or are contraindicated, and the patient cannot tolerate PT/chiropractic.
- Conservative therapy required before initial chronic ESI: ≥4 weeks chiropractic/PT or prescribed home exercise; NSAID ≥3 weeks (or contraindicated/not tolerated); ≥4 weeks activity modification
- Acute pain (<3 months): one ESI allowed when severe radicular pain interferes with ADLs, NSAID/opiate therapy tried (≥3 days) or contraindicated, and injection used as bridge to therapy
Required Clinical Documentation
Authorization requests must include clinical documentation supporting the indication and severity of symptoms, how pain affects activities of daily living, dates and details of prior conservative therapies (including start and end dates), imaging confirming the anatomic cause (e.g., disc herniation, spinal stenosis, degenerative changes), and documentation of response to prior ESIs when applicable. Requests for second or subsequent ESIs must document time elapsed since prior injections and degree/duration of benefit (≥50% relief and functional improvement for continuation criteria).
- Document indication and severity and impact on ADLs
- Provide dates and details of prior conservative therapy attempts
- Include imaging that confirms the anatomic source of radicular pain
- For subsequent ESIs, document elapsed time since prior ESI(s) and objective benefit (e.g., ≥50% pain relief for continuation)
Imaging Guidance for Epidural Steroid Injections
Imaging guidance (fluoroscopy or CT) required for caudal/interlaminar ESIs
Fluoroscopy or CT imaging guidance is required for caudal or interlaminar ESIs except in rare instances with documented justification; procedures are expected to be performed by a physician using imaging guidance.
- Standard fluoroscopy or CT should be used for procedural guidance.
- Deviations require documented justification.
Imaging confirmation required to support initial chronic ESI
For an initial ESI for chronic radicular pain, imaging confirmation of the causative pathology (e.g., disc herniation or stenosis) is required to support medical necessity.
- Physical exam and imaging must confirm spinal stenosis, disc herniation, or degenerative vertebral changes.
Definitions
Background
Epidural steroid injections deliver a glucocorticoid and/or anesthetic into the epidural space via caudal or interlaminar approaches. These procedures are used for radiculopathy, spinal stenosis, disc herniation, and related radicular pain to provide short‑term pain relief and functional improvement, particularly for patients with significant impairment of activities of daily living who have not responded to conservative therapies.
Not Covered / Exclusions
The policy lists the following conditions as not covered: third or subsequent caudal or interlaminar ESIs for chronic pain when there was no improvement after the first two injections; continuation of injections beyond 12 months; and more than four therapeutic injections within any 12‑month period. The policy states these are not medically necessary because effectiveness and safety have not been established.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.